-
developmental biology, cell biology and evolutionary biology. We like to implement novel omics technologies such as single cell approaches and chemical biology to help us answering our biological questions
-
vision . You act with attention to quality, integrity, creativity and cooperation. You have excellent communication and writing skills in English You comply with the FWO Post Doc and Marie Sklodowska-Curie
-
including fragmentomics, methylomics, etc). In addition, results will be compared and integrated with bulk and single-cell/spatial data obtained on matching tumor cells. About TOBI-lab The overarching goal
-
and motivation. Ideal candidates will possess critical thinking abilities, excellent oral and written communication skills in English, and a collaborative mindset. Additionally, they should demonstrate
-
question: « what makes our brain human ? » (Vanderhaeghen and Polleux, Nat. Rev. Neurosci. 2023). We combine cutting-edge approaches such as pluripotent stem cell models of human corticogenesis, human-mouse
-
vision . You act with attention to quality, integrity, creativity and cooperation. You have excellent communication and writing skills in English You comply with the FWO Post Doc and Marie Sklodowska-Curie
-
innovative research on how tissue-resident macrophages respond to pathological stimuli and influence brain homeostasis. Apply cutting-edge techniques including spectral flow cytometry, spatial and single-cell
-
description The research is a collaborative effort between both labs to explore plant-fungi interactions mediated by specialized metabolites. Beyond their role in chemical communication, these metabolites hold
-
to be associated with a typical XBP1-driven gene signature (Osorio et al, Nat Imm, 2014 and Tavernier et al., Nat Cell Biol, 2017), but rather with RIDD, and appears closely linked with apoptotic cell
-
single-cell and spatial multi-omics datasets. The primary focus of this role is to delve deeper into the molecular mechanisms driving intra-tumor heterogeneity, plasticity, and therapy resistance